Tag: Boltz-2
-
AI Breakthrough: How Boltz-2 Is Accelerating Drug Discovery by 1000x
Scientists at the Massachusetts Institute of Technology, in collaboration with the biotechnology startup Recursion and engineers from NVIDIA, have unveiled Boltz-2—a groundbreaking biomolecular AI system designed to radically accelerate drug discovery. Released under the MIT license in June, this model integrates the prediction of three-dimensional structures with the assessment of molecular binding affinities into a…